Roman Butler Fullerton & Co’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $477K | Hold |
7,364
| – | – | 0.14% | 150 |
|
2025
Q1 | $474K | Sell |
7,364
-2,437
| -25% | -$157K | 0.18% | 125 |
|
2024
Q4 | $687K | Sell |
9,801
-770
| -7% | -$54K | 0.22% | 107 |
|
2024
Q3 | $765K | Hold |
10,571
| – | – | 0.23% | 101 |
|
2024
Q2 | $728K | Hold |
10,571
| – | – | 0.24% | 97 |
|
2024
Q1 | $693K | Sell |
10,571
-988
| -9% | -$64.8K | 0.26% | 94 |
|
2023
Q4 | $760K | Buy |
11,559
+513
| +5% | +$33.7K | 0.3% | 84 |
|
2023
Q3 | $672K | Sell |
11,046
-149
| -1% | -$9.07K | 0.32% | 85 |
|
2023
Q2 | $708K | Sell |
11,195
-1,376
| -11% | -$87.1K | 0.33% | 85 |
|
2023
Q1 | $797K | Sell |
12,571
-226
| -2% | -$14.3K | 0.4% | 80 |
|
2022
Q4 | $819K | Sell |
12,797
-3,804
| -23% | -$243K | 0.42% | 75 |
|
2022
Q3 | $965K | Buy |
16,601
+25
| +0.2% | +$1.45K | 0.61% | 52 |
|
2022
Q2 | $1.03M | Buy |
16,576
+23
| +0.1% | +$1.42K | 0.57% | 53 |
|
2022
Q1 | $1.09M | Sell |
16,553
-3,121
| -16% | -$205K | 0.5% | 60 |
|
2021
Q4 | $1.35M | Buy |
19,674
+11,539
| +142% | +$792K | 0.6% | 53 |
|
2021
Q3 | $517K | Buy |
8,135
+494
| +6% | +$31.4K | 0.24% | 105 |
|
2021
Q2 | $487K | Buy |
7,641
+3
| +0% | +$191 | 0.24% | 110 |
|
2021
Q1 | $465K | Sell |
7,638
-2,145
| -22% | -$131K | 0.23% | 117 |
|
2020
Q4 | $565K | Buy |
9,783
+9
| +0.1% | +$520 | 0.33% | 89 |
|
2020
Q3 | $514K | Buy |
9,774
+7
| +0.1% | +$368 | 0.34% | 91 |
|
2020
Q2 | $486K | Sell |
9,767
-1,280
| -12% | -$63.7K | 0.35% | 91 |
|
2020
Q1 | $475K | Buy |
11,047
+1,827
| +20% | +$78.6K | 0.42% | 74 |
|
2019
Q4 | $459K | Buy |
9,220
+1,987
| +27% | +$98.9K | 0.3% | 103 |
|
2019
Q3 | $314K | Buy |
7,233
+16
| +0.2% | +$695 | 0.22% | 133 |
|
2019
Q2 | $325K | Buy |
7,217
+14
| +0.2% | +$630 | 0.22% | 134 |
|
2019
Q1 | $321K | Buy |
7,203
+14
| +0.2% | +$624 | 0.22% | 137 |
|
2018
Q4 | $304K | Buy |
+7,189
| New | +$304K | 0.26% | 122 |
|